ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½Π°Ρ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΡ ΡΠΈΠ·ΠΈΠΊΠΎ-Ρ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² Π² ΠΆΠΈΠ²ΡΡ ΡΠΈΡΡΠ΅ΠΌΠ°Ρ ΠΏΡΠΈ ΠΏΠΎΠΌΠΎΡΠΈ Π±ΠΈΠΎΡΠΎΠ²ΠΌΠ΅ΡΡΠΈΠΌΡΡ Π·ΠΎΠ½Π΄ΠΎΠ²: Π½ΠΎΠ²ΡΠ΅ ΠΏΠΎΠ΄Ρ ΠΎΠ΄Ρ
ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ
Π‘ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΠΊΠΎΠ½ΡΡΠ°ΡΡΠΈΡΡΡΡΠ΅Π³ΠΎ Π·ΠΎΠ½Π΄Π° PGC-GdDTPA ΠΎΡΡΡΠ΅ΡΡΠ²Π»Π΅Π½Π° Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΡ Π°Π½Π³ΠΈΠΎΠ³Π΅Π½Π΅Π·Π° ΡΠ°ΠΊΠΎΠ²ΡΡ ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ . ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Π·ΠΎΠ½Π΄ PGC-GdDTPA ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΠ Π’ ΠΈΠ·ΠΌΠ΅ΡΡΡΡ ΡΠ°Π½Π½ΠΈΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ Π² ΠΊΡΠΎΠ²ΠΎΡΠ½Π°Π±ΠΆΠ΅Π½ΠΈΠΈ ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ. ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΈ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΠΈΡΡΠΎΡΠ½ΠΈΠΊΠΎΠ² ΠΏΡΠΎΡΠ΅ΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π² ΡΠ°ΠΊΠΎΠ²ΡΡ ΠΎΠΏΡΡ ΠΎΠ»ΡΡ ΠΏΡΡΠ΅ΠΌ ΡΠ»ΡΠΎΡΠ΅ΡΡΠ΅Π½ΡΠ½ΠΎΠΉ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ Π² ΠΈΠ½ΡΠ°ΠΊΡΠ½ΡΡ ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ Π² Π±Π»ΠΈΠΆΠ½Π΅ΠΌ ΠΈΠ½ΡΡΠ°ΠΊΡΠ°ΡΠ½ΠΎΠΌ Π΄ΠΈΠ°ΠΏΠ°Π·ΠΎΠ½Π΅ Π΄Π»ΠΈΠ½… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΠΠΠΠ 1. ΠΠ ΠΠΠ¦ΠΠΠ« ΠΠΠΠΠΠΠΠΠΠΠΠ ΠΠΠΠΠΠ£ΠΠ―Π ΠΠΠ ΠΠΠ£ΠΠΠΠΠΠ¦ΠΠ Π ΠΠΠΠ«Π₯ Π‘ΠΠ‘Π’ΠΠΠΠ₯ (ΠΠΠΠΠ ΠΠΠ’ΠΠ ΠΠ’Π£Π Π«)
- 1. 1. ΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅
- 1. 2. ΠΡΠΈΠ±ΠΎΡΠ½ΠΎΠ΅ ΠΎΠ±ΠΎΡΡΠ΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠΉ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ
- 1. 3. ΠΠΎΠΌΠΏΡΡΡΠ΅ΡΠ½ΡΠ΅ ΠΈ ΠΌΠ°Π³Π½ΠΈΡΠ½ΠΎ-ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ½ΡΠ΅ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄Ρ
- 1. 4. Π Π°Π΄ΠΈΠΎΠ½ΡΠΊΠ»ΠΈΠ΄Ρ ΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½Π°Ρ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΡ
- 1. 5. ΠΠ΅ΡΠΎΠ΄Ρ ΠΎΠΏΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ
- 1. 6. Π£Π»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²Π°Ρ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΡ
- 1. 7. ΠΠΎΠ½Π΄Ρ Π΄Π»Ρ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠΉ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ
- ΠΠΠΠΠ 2. Π’ΠΠΠ ΠΠ’ΠΠ§ΠΠ‘ΠΠΠ ΠΠ‘ΠΠΠΠ« Π ΠΠΠΠ’Π« (ΠΠΠΠΠ ΠΠΠ’ΠΠ ΠΠ’Π£Π Π«)
- 2. 1. ΠΠ΅ΡΠΎΠ΄Ρ ΠΌΠ°Π³Π½ΠΈΡΠ½ΠΎ-ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ½ΠΎΠΉ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΠΈ ΠΈ ΠΊΠΎΠ½ΡΡΠ°ΡΡΠΈΡΡΡΡΠΈΠ΅ Π²Π΅ΡΠ΅ΡΡΠ²Π°
- 2. 2. ΠΠΎΠ½ΡΡΠ°ΡΡΠΈΡΡΡΡΠΈΠ΅ Π·ΠΎΠ½Π΄Ρ Π² ΠΠ Π’
- 2. 3. ΠΠΎΠ΄Ρ ΠΎΠ΄Ρ ΠΊ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΡ ΡΠ΅Π»Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΏΡΠΈ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ΅ ΠΠ Π’-ΠΊΠΎΠ½ΡΡΠ°ΡΡΠΈΡΡΡΡΠΈΡ Π·ΠΎΠ½Π΄ΠΎΠ²
- 2. 4. Π‘Π΅Π½ΡΠΎΡΠ½ΡΠ΅ ΠΊΠΎΠ½ΡΡΠ°ΡΡΠΈΡΡΡΡΠΈΠ΅ Π·ΠΎΠ½Π΄Ρ Π² ΠΠ Π’
- 2. 5. Π€Π΅ΡΠΌΠ΅Π½Ρ-ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΠΠ Π’-ΠΊΠΎΠ½ΡΡΠ°ΡΡΠΈΡΡΡΡΠΈΠ΅ Π²Π΅ΡΠ΅ΡΡΠ²Π°
- 2. 2. Π‘Π΅Π½ΡΠΎΡΠ½ΡΠ΅ ΠΠ Π’-ΠΊΠΎΠ½ΡΡΠ°ΡΡΠΈΡΡΡΡΠΈΠ΅ Π²Π΅ΡΠ΅ΡΡΠ²Π°, ΠΎΡΠ½ΠΎΠ²Π°Π½Π½ΡΠ΅ Π½Π° ΡΡΡΠ΅ΠΊΡΠ΅ Ρ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π°-ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠ° ΡΠΏΠΈΠ½ΠΎΠ²ΠΎΠ³ΠΎ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ (Π₯Π-ΠΠ‘Π)
- 2. 7. ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄Π° ΠΠ Π’ ΠΈ ΠΊΠΎΠ½ΡΡΠ°ΡΡΠΈΡΡΡΡΠΈΡ Π·ΠΎΠ½Π΄ΠΎΠ² Π΄Π»Ρ ΠΌΡΠ»ΡΡΠΈΠΊΠΎΠΏΠΈΠΉΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΡΠΊΠ°Π½ΠΈ
- 2. 8. Π’ΠΈΠΏΡ ΡΠ»ΡΠΎΡΠ΅ΡΡΠ΅Π½ΡΠ½ΡΡ Π·ΠΎΠ½Π΄ΠΎΠ² Π΄Π»Ρ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ Π² ΠΆΠΈΠ²ΡΡ ΡΠΈΡΡΠ΅ΠΌΠ°Ρ
- 2. 9. Π‘Π°ΠΌΠΎΡΡΡΠ΅Π½ΠΈΠ΅ ΡΠ»ΡΠΎΡΠ΅ΡΡΠ΅Π½ΡΠΈΠΈ ΠΈ ΠΊΠΎΠ½ΡΡΠ°ΡΡΠΈΡΡΡΡΠΈΠ΅ Π·ΠΎΠ½Π΄Ρ
- ΠΠΠΠΠ 3. ΠΠΠΠΠ ΠΠ‘ΠΠΠΠΠ«Π₯ ΠΠΠ‘ΠΠΠ ΠΠΠΠΠ’ΠΠΠ¬ΠΠ«Π₯ ΠΠΠ’ΠΠΠΠ, ΠΠ‘ΠΠΠΠ¬ΠΠΠΠΠΠΠ«Π₯ Π ΠΠΠ‘Π‘ΠΠ Π’ΠΠ¦ΠΠΠΠΠΠ Π ΠΠΠΠ’Π
- 3. 1. Π₯ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠΈΠ½ΡΠ΅Π·
- 3. 2. ΠΡΠ»ΡΡΡΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ
- 3. 3. ΠΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΠ΅ ΠΆΠΈΠ²ΠΎΡΠ½ΡΠ΅
- 3. 4. ΠΠ΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½Π°Ρ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΡ Π² ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ
- ΠΠΠΠΠ 4. ΠΠΠΠ ΠΠΠΠΠΠΠ£ΠΠ―Π ΠΠ«Π ΠΠΠΠΠ’Π« («ΠΠΠΠ-ΠΠΠΠΠ«») ΠΠΠ― ΠΠΠΠ£ΠΠΠΠΠΠ¦ΠΠ Π€ΠΠ ΠΠΠΠ’ΠΠ’ΠΠΠΠΠ ΠΠΠ’ΠΠΠΠΠ‘Π’Π Π ΠΠΠΠ«Π₯ Π‘ΠΠ‘Π’ΠΠΠΠ₯
- 4. 1. ΠΠΎΠ»ΠΈΠΌΠ΅ΡΠ½ΡΠΉ Π±ΠΈΠΎΡΠΎΠ²ΠΌΠ΅ΡΡΠΈΠΌΡΠΉ Π·ΠΎΠ½Π΄ (PGC) Π΄Π»Ρ Π΄ΠΎΡΡΠ°Π²ΠΊΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΊΠΎΠ½ΡΡΠ°ΡΡΠΈΡΡΡΡΠΈΡ Π²Π΅ΡΠ΅ΡΡΠ²
- 4. 2. ΠΡΠΈΠΌΠ΅Π½Π΅ΠΈΠ΅ PGC-Π·ΠΎΠ½Π΄Π° ΠΏΡΠΈ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΈΠ½ΡΠ°ΠΊΡΠ½ΠΎΡΡΠΈ ΡΠΎΡΡΠ΄ΠΎΠ² ΠΈ ΠΏΡΠΈ Π΄ΠΎΡΡΠ°Π²ΠΊΠ΅ ΠΊΠΎΠ½ΡΡΠ°ΡΡΠΈΡΡΡΡΠΈΡ Π²Π΅ΡΠ΅ΡΡΠ²
- 4. 3. Π‘ΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π² ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΎΠΏΡΡ ΠΎΠ»ΠΈ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ Π°Π½ΡΠΈΡΠ΅Π» ΠΈ PGC-Gd-Π·ΠΎΠ½Π΄Π°
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- Achilefu, S. (2004). «Lighting up tumors with receptor-specific optical molecular probes.» Technol Cancer ' Res Treat 3(4): 393−409.
- Aime, S., Botta, M., Fasano, M., Geninatti Crich, S. and Terreno, E. (1999). «lh and 17o-nmr relaxometric investigations of paramagnetic contrast agents for mri. Clues for higher relaxivities.» Coord Chem Rev 186: 321 333.
- Aime, S., Botta, M., Panero, M., Grandi, M. and Uggeri, F. (1991). «Inclusion complexes between b-cyclodextrin and b-benzyloxy-a-propionic derivatives of paramagnetic dota- and dtpa-gadolinium (iii) complexes.» Magn Reson Chem 29(9): 923−927.
- Aime, S., Cavallotti, C., Gianolio, E., Giovenzana, G. B., Palmisano, G. and Sisti, M. (2004). «Mannich reaction as a new route to pyridine-based polyaminocarboxylic ligands.» Org Lett 6(8): 1201−1204.
- Aime, S., Delli Castelli, D., Fedeli, F. and Terreno, E.2002). «A paramagnetic mri-cest agent responsive to lactate concentration.» J Am Chem Soc 124(32): 9364−9365.
- Anderson, H. L., Yap, J. T., Miller, M. P., Robbins, A., Jones, T. and Price, P. M. (2003). «Assessment ofpharmacodynamic vascular response in a phase i trial of combretastatin a4 phosphate.comment.» J Clin Oncol.21 (15): 2823−2830.
- Andre, J. P., Toth, E., Fischer, H., Seelig, A., Macke, H. R. and Merbach, A. E. (1999). «High relaxivity for monomeric gd (dota)-based mri contrast agents, thanks to micellar self-organization.» Chemistry Eur J 5(10): 29 772 983.
- Aoki, T., Kataoka, H., Morimoto, M., Nozaki, K. and Hashimoto, N. (2007). «Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats.» Stroke 38(1): 162−169.
- Arridge, S. R., Schweiger, M., Hiraoka, M. and Delpy, D. T. (1993). «A finite element approach for modeling photon transport in tissue.» Med Phys 20(2 Pt 1): 299−309.
- Artemov, D., Bhujwalla, Z. M. and Bulte, J. W. (2004). «Magnetic resonance imaging of cell surface receptors using targeted contrast agents.» Curr Pharm Biotechnol 5(6): 485 494.
- Badruddoja, M. A., Krouwer, H. G., Rad, S. D., Rebro, K. J., Pathak, P. A. and Schmainda, K. M. (2003). «Antiangiogenic effects of dexamethasone in 91 gliosarcoma assessed by mri cerebral blood volume maps.» Neuro-oncol 5(4): 235−243.
- Ballou, B. (2005) . «Quantum dot surfaces for use in vivo and in vitro.» Curr Top Dev Biol 70: 103−120.
- Ballou, B., Fisher, G. W., Deng, J. S., Hakala, T. R., Srivastava, M. and Farkas, D. L. (1998). «Cyanine fluorochrome-labeled antibodies in vivo: Assessment of tumor imaging using cy3, cy5, cy5.5, and cy7.» Bioconj Chem22 (3): 251−257.
- Basu, S., Zhuang, H., Torigian, D. A., Rosenbaum, J., Chen, W. and Alavi, A. (2009). «Functional imaging of inflammatory diseases using nuclear medicine techniques.» Semin Nucl Med 39(2): 124−145.
- Becker, A., Hessenius, C., K, L., Ebert, B., Sukowski, U., Semmler, W., Wiedenmann, B. and Grotzinger, C. (2001). «Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands.» Nature Biotechnol 19(4): 327−331.
- Ben-Ari, E. T. (2003). «Nanoscale quantum dots hold promise for cancer applications.» J Natl Cancer Inst 95(7): 502 504.
- Berman, D. S., Kiat, H., Van Train, K., Friedman, J. D., Wang, F. P. and Germano, G. (1994). «Dual-isotope myocardial perfusion spect with rest thallium-201 and stress tc-99m sestamibi.» Cardiol Clin 12(2): 261−270.
- Berridge, M. S. and Tewson, T. J. (1986). «Chemistry of fluorine-18 radiopharmaceuticals.» Int J Rad Appl Instrum A 37(8): 685−693.
- Bertolino, C., Caputo, G., Barolo, C., Viscardi, G. and Coluccia, S. (2006). «Novel heptamethine cyanine dyes with large stokes' shift for biological applications in the near infrared.» J Fluoresc 16(2): 221−225.
- Bevilacqua, M. P., Pober, J. S., Mendrick, D. L., Cotran, R. S. and Gimbrone, M. A., Jr. (1987). «Identification of an inducible endothelial-leukocyte adhesion molecule.» Proc Natl Acad Sci USA 84(24): 9238−9242.
- Bhaumik, S. and Gambhir, S. S. (2002). «Optical imaging of renilla luciferase reporter gene expression in living mice.» Proc Natl Acad Sci USA 99(1): 377−382.
- Bhaumik, S., Lewis, X. Z. and Gambhir, S. S. (2004). «Optical imaging of renilla luciferase, synthetic renillaluciferase, and firefly luciferase reporter gene expression in living mice.» J Biomed Opt 9(3): 578−586.
- Bischoff, J., Brasel, C., Kraling, B. and Vranovska, K. (1997). «E-selectin is upregulated in proliferating endothelial cells in vitro.» Microcirculation 4(2): 279 287.
- Blasberg, R. G. and Gelovani Tjuvajev, J. (2002). «Molecular-genetic imaging: A nuclear medicine-based perspective in vivo imaging of molecular-genetic targets for cancer therapy.» Mol Imag 1(3): 280−300.
- Boerman, 0. C., Dams, E. T., Oyen, W. J., Corstens, F. H. and Storm, G. (2001). «Radiopharmaceuticals for scintigraphic imaging of infection and inflammation.» Inflamm Res 50(2): 55−64.
- Bogdanov, A., Jr., Kang, H. W., Querol, M., Pretorius, P. H. and Yudina, A. (2007). «Synthesis and testing of a binary catalytic system for imaging of signal amplification in vivo.» Bioconjug Chem 18(4): 1123−1130.
- Bogdanov, A., Jr., Matuszewski, L., Bremer, C., Petrovsky, A. and Weissleder, R. (2002). «Oligomerization of paramagnetic substrates result in signal amplification and can be used for mr imaging of molecular targets.» Mol Imaging 1(1): 16−23.
- Bogdanov, A., Jr., Wright, S. C., Marecos, E. M., Bogdanova, A., Martin, C., Petherick, P. and Weissleder, R. (1997). «A long-circulating co-polymer in „Passive targeting“ To solid tumors.» J Drug Targeting 4(5): 321 330.
- Bogdanov, A. A., Jr. (2008). «Merging molecular imaging and rna interference: Early experience in live animals.» J Cell Biochem.
- Bogdanov, A. A., Jr., Callahan, R. J., Wilkinson, R. A., Martin, C., Cameron, J. A., Fischman, A. J., Brady, T. J. and Weissleder, R. (1994). «Synthetic copolymer kit for radionuclide blood-pool imaging.» J Nucl Med 35(11): 18 801 886.
- Bogdanov, A. A., Lewin, M. and Weissleder, R. (1999). «Approaches and agents for imaging the vascular system.» Adv Drug Deliv Rev 37(1−3): 279−293.
- Bogdanov, A. A., Querol, M. and Chen, J. W. (2007). «visualization of the enzymatic activity in living systems using activated nmr contrast agents.» Biofizika 52(3): 389−400.
- Bogdanov, A. A. J. and Weissleder, R. (1998). «The development of in vivo imaging systems to study gene expression.» Trends Biotech. 16: 5−10.
- Bogdanov, A. J., Matuszewski, L., Bremer, C., Petrovsky, A. and Weissleder, R. (2002). «Oligomerization of paramagnetic substrates results in signal amplification and can be used for MR imaging of molecualr targets.» Mol. Imag 1(1): 1623.
- Bogdanov, A. J., Weissleder, R. and Brady, T. (1995). «Long-circulating blood pool imaging agents.» Adv Drug Del Rev 16: 335−348.
- Bogdanov, A. J., Weissleder, R., Tsai, E., Schaffer, B., Bogdanova, A., Nossiff, N., Papisov, M. and Brady, T. (1993). Tumor neovascularity imaging by contrast-enhanced MR angiography. Proc 12th Sci Mtg Soc Magn Reson Med, NY, Berkeley, CA: SMRM.
- Bottrill, M., Kwok, L. and Long, N. J. (2006). «Lanthanides in magnetic resonance imaging.» Chem Soc Rev 35(6): 557 571.
- Boxerman, J. L., Hamberg, L. M., Rosen, B. R. and Weisskoff, R. M. (1995). «Mr contrast due to intravascular magnetic susceptibility perturbations.» Magn Reson Med. 34(4): 555−566.
- Brasch, R., Pham, C., Shames, D., Roberts, T., van Dijke, K., van Bruggen, N., Mann, J., Ostrowitzki, S. and Melnyk, O. (1997). «Assessing tumor angiogenesis using macromolecular mr imaging contrast media. 40 refs.» J Magn Reson Imaq 7(1): 68−74.
- Bredow, S., Lewin, M., Hofmann, B., Marecos, E. and Weissleder, R. (2000). «Imaging of tumour neovasculature by targeting the tgf-b binding receptor endoglin.» Eur. J. Cancer 36: 675−681.
- Bremer, C., Tung, C. H. and Weissleder, R. (2001). «In vivo molecular target assessment of matrix metalloproteinase inhibition.» Nat Med 7(6): 743−748.
- Brucher, E. and Sherry, A. D. (2001). Stability and toxicity of contrast agents. The chemistry of contrast agents in medical magnetic resonance imaging. A. E. Merbach and E. Toth. Chichester, John Wiley & Sons, Ltd: pp 243 281.
- Burton, D. W., Geller, J., Yang, M., Jiang, P., Barken, I., Hastings, R. H., Hoffman, R. M. and Deftos, L. J. (2005). «Monitoring of skeletal progression of prostate cancer by GFP imaging, x-ray, and serum OPG and PTHRP.» Prostate 62 (3): 275−281.
- Cai, W., Shin, D. W., Chen, K., Gheysens, O., Cao, Q., Wang, S. X., Gambhir, S. S. and Chen, X. (2006). «Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.» Nano Lett 6(4): 669−676.
- Cairns, R. A. and Hill, R. P. (2004). «A fluorescent orthotopic model of metastatic cervical carcinoma.» Clin Exp Metastasis 21(3): 275−281.
- Callahan, R., Wilkinson, R., Bogdanov, A. J., Donahue, K., Weissleder, R. and Fischman, A. (1995). Validation of plasma volume determinations in the rat using an in-Ill labeled polymer and 1−125 labeled human serum albumin. J. Nucl. Med. 36: 157P.
- Callahan, R. J., Bogdanov, A., Jr., Fischman, A. J., Brady, T. J. and Weissleder, R. (1998). «Preclinical evaluation and phase i clinical trial of a 99mtc-labeled synthetic polymer used in blood pool imaging.» Amer J Roentgenol 171 (1): 137−143.
- Callahan, R. J., Froelich, J. W., McKusick, K. A., Leppo, J. and Strauss, H. W. (1982). «A modified method for the in vivo labeling of red blood cells with tc-99m: Concise communication.» J Nucl Med 23(4): 315−318.
- Campbell, R. E., Tour, O., Palmer, A. E., Steinbach, P. A., Baird, G. S., Zacharias, D. A. and Tsien, R. Y. (2002). «A monomeric red fluorescent protein.» Proc Natl Acad Sci U S A 99(12): 7877−7882.
- Campo, M. A. and Lange, N. (2006). «Fluorescence diagnosis using enzyme-related metabolic abnormalities of neoplasia.» J Environ Pathol Toxicol Oncol 25(1): 341−372.
- Carey, M. and Smale, S. (2001). Transcriptional regulation in eukaryotes: Concepts, strategies, and techniques, CHSL Press.
- Castano, A. P., Liu, Q. and Hamblin, M. R. (2006). «A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy.» British J Cancer 94(3): 391−397.
- Chang, E., Miller, J. S., Sun, J., Yu, W. W., Colvin, V. L., Drezek, R. and West, J. L. (2005). «Protease-activated quantum dot probes.» Biochem Biophys Res Commun 334(4): 1317−1321.
- Chatziioannou, A. F. (2002) . «Molecular imaging of small animals with dedicated pet tomographs.» Eur J Nucl Med Mol Imaq. 29 (1): 98−114.
- Chatziioannou, A. F. (2005). «Instrumentation for molecular imaging in preclinical research: Micro-pet and micro — spect.» Proc Am Thorac Soc 2(6): 533−536.
- Chen, J., Querol, M., Bogdanov, A. J. and Weissleder, R.2006). «Imaging myeloperoxidase in mice using novel amplifiable paramagnetic substrates.» Radiology 238(8): in press.
- Chen, J. W., Pham, W., Weissleder, R. and Bogdanov, A., Jr. (2004). «Human myeloperoxidase: A potential target foir molecular mr imaging in atherosclerosis.» Magn Reson Meci 52(5): 1021−1028.
- Chen, J. W., Querol Sans, M., Bogdanov, A., Jr. and. Weissleder, R. (2006). «Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates.» Radiology 240 (2): 473−481.
- Chen, X., Conti, P. S. and Moats, R. A. (2004). «In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts.» Cancer Res 64(21): 8009−8014.
- Cherry, S. R. (2006). «The 2006 henry n. Wagner lecture: Of mice and men (and positrons)—advances in pet imaging technology.» J Nucl Med 47(11): 1735−1745.
- Clarke, S. E., Weinmann, H. J., Dai, E., Lucas, A. R. and Rutt, B. K. (2000). «Comparison of two blood pool contrast agents for 0.5-t mr angiography: Experimental study in rabbits.» Radiology 214(3): 787−794.
- Contag, C. H. and Bachmann, M. H. (2002). «Advances in in vivo bioluminescence imaging of gene expression. 14 6 refs.» Annual Review of Biomedical Engineering. 4: 235 260.
- Contag, C. H., Jenkins, D., Contag, P. R. and Negrin, R. S. (2000). «Use of reporter genes for optical measurements of neoplastic disease in vivo. 92 refs.» Neoplasia (New York) 2 (1−2): 41−52.
- Contag, C. H., Spilman, S. D., Contag, P. R., Oshiro, M., Eames, B., Dennery, P., Stevenson, D. K. and Benaron, D. A. (1997). «Visualizing gene expression in living mammalsusing a bioluminescent reporter.» Photochem Photobiol 66(4): 523−531.
- Correas, J. M., Bridal, L., Lesavre, A., Mejean, A., Claudon, M. and Helenon, 0. (2001). «Ultrasound contrast agents: Properties, principles of action, tolerance, and artifacts.» Eur Radiol 11(8): 1316−1328.
- De Leon-Rodriguez, L. M., Lubag, A. J., Malloy, C. R., Martinez, G. V., Gillies, R. J. and Sherry, A. D. (2009). «Responsive mri agents for sensing metabolism in vivo.» Acc Chem Res 42 (7): 948−957 .
- Dennie, J., Mandeville, J., Boxerman, J., Packard, S., Rosen, B. and Weisskoff, R. (1998). «Nmr imaging of changes in vascular morphology due to tumor angiogenesis.» Magn. Reson. Med. 40(6): 793−799.
- Dong, Q., Hurst, D. R., Weinmann, H. J., Chenevert, T. L., Londy, F. J. and Prince, M. R. (1998). «Magnetic resonance angiography with gadomer-17. An animal study original investigation.» Invest Radiol 33(9): 699−708.
- Drevs, J., Hofmann, I., Hugenschmidt, H., Wittig, C., Madjar, H., Muller, M., Wood, J., Martiny-Baron, G., Unger,
- Duimstra, J. and Meade Thomas, J. (2005). Self-immolative magnetic resonance imaging contrast agents sensitive to beta-glucuronidase. USA: patent W005115105A2 pp. 62.
- Edinger, M., Sweeney, T. J., Tucker, A. A., Olomu, A. B., Negrin, R. S. and Contag, C. H. (1999). «Noninvasive assessment of tumor cell proliferation in animal models.» Neoplasia (New York) 1(4): 303−310.
- Esser, P. D. (1985). «Improvements in spect technology for cerebral imaging.» Semin Nucl Med 15(4): 335−346.
- Fabbro, D., Ruetz, S., Bodis, S., Pruschy, M., Csermak, K., Man, A., Campochiaro, P., Wood, J., O’Reilly, T. and Meyer, T. (2000). «Pkc412—a protein kinase inhibitor with a broad therapeutic potential.» Anti-Cancer Drug Design 15(1): 1728.
- Fischman, A. J., Babich, J. W., Barrow, S. A., Graham, W., Carter, E., Tompkins, R. G. and Rubin, R. H. (1995). «Detection of acute bacterial infection within soft tissue injuries using a 99mtc-labeled chemotactic peptide.» J Trauma 38(2): 223−227.
- Fischman, A. J., Babich, J. W. and Rubin, R. H. (1994). «Infection imaging with technetium-99m-labeled chemotactic peptide analogs.» Semin Nucl Med 24(2): 154−168.
- Fitz Gerald, K., Holliger, P. and Winter, G. (1997). «Improved tumor targeting by disulphide stabilized diabodies expressed in pichia pastoris.» Protein Eng 10: 1221−1225.
- Foilli, S., Westermann, P., Braichotte, D., Pelegrin, A., Wagnieres, G., van den Bergh, H. and Mach, J.-P. (1994). «Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice.» Cancer Res 54 (10): 2643−2649.
- Folkman, J. (1995). «Angiogenesis in cancer, vascular, rheumatoid and other disease. 72 refs.» Nature Medicine 1(1): 27−31.
- Forsen, S. and Hoffman, R. A. (1963). «Study of moderate rapid chemical exchange reactions by means of nuclear magnetic double resonance.» J Chem Phys 39(11): 2892−2901.
- Fossheim, S., Saebo, K. B., Fahlvik, A. K., Rongved, P. and Klaveness, J. (1997). «Low molecular weight lanthanide contrast agents: In vitro studies of mechanisms of action.» J Magn Reson Imag 7(1): 251−257.
- Fossheim, S. L., Fahlvik, A. K., Klaveness, J. and Muller, R. N. (1998). «Paramagnetic liposomes as mri contrast agents: Influence of liposomal physicochemical properties on the in vitro relaxivity.» Magnetic Resonance Imaging 17 (1): 83−89.
- Frank, H., Weissleder, R., Bogdanov, A. A., Jr. and Brady, T. J. (1994). «Detection of pulmonary emboli by using mr angiography with mpeg-pl-gddtpa: An experimental study in rabbits.» Amer J Roentgenol 162(5): 1041−1046.
- Frouge, C., Guinebretiere, J. M., Contesso, G., Di Paola, R. and Blery, M. (1994). «Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis.» Invest Radiol 29(12): 10 431 049.
- Fujimori, E. (1989). «Cross-linking and fluorescence changes of collagen by glycation and oxidation.» Biochim Biophys Acta 998(2): 105−110.
- Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Parks, E. C., Lu, N., Selig, M., Nielson, G., Taksir, T., Jain, R. K. and Seed, B. (1998). «Tumor induction of vegf promoter activity in stromal cells.» Cell 125(2):715−725.
- Funovics, M., Montet, X., Reynolds, F., Weissleder, R. and Josephson, L. (2005). «Nanoparticles for the optical imaging of tumor E-selectin.» Neoplasia (New York) 7(10): 904−911.
- Gimbrone, M. A., Jr., Topper, J. N., Nagel, T., Anderson, K. R. and Garcia-Cardena, G. (2000). «Endothelial dysfunction, hemodynamic forces, and atherogenesis. «Ann N Y Acad Sci 902: 230−239.
- Golman, K., Olsson, L. E., Axelsson, 0., Mansson, S., Karlsson, M.β’ and Petersson, J. S. (2003). «Molecular imaging using hyperpolarized 13c.» Br J Radiol 76(2): S118−127, 2003.
- Gonzalez, C. F., Chou, Y. I., Ortega, H. V. and Moret, J. (1992). «Intracranial aneurysms: Flow analysis of their origin and progression.» AJNR Am J Neuroradiol. 13(1): 181 188.
- Grant, C. W., Karlik, S. and Florio, E. (1989). «A liposomal mri contrast agent: Phosphatidylethanolamine-dtpa.» Magn Reson Med 49(3):468−78 11(2): 236−243.
- Gueven, N., Fukao, T., Luff, J., Paterson, C., Kay, G., Kondo, N. and Lavin, M. F. (2006). «Regulation of the atm promoter in vivo.» Genes Chromosomes Cancer 45(1):61−71 45(1): 61−71.
- Guo, H., Krutzsch, H., Inman, J., Shannon, C. and and Roberts, D. (1997). «Anti-proliferative and anti-tumor activities of d-reverse peptides from the second type-1 repeat od thrombospondin-1.» J Pept Res 50(3): 210−217.
- Guo, N., Krutzxch, H., Inman, J. and Roberts, D. (1997). «Thrombospondin 1 and type i repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells.» Cancer Res 57(9): 1735−1742.
- Gupta, H., Weissleder, R., Bogdanov, A. A., Jr. and Brady, T. J. (1995). «Experimental gastrointestinal hemorrhage: Detection with contrast-enhanced mr imaging and scintigraphy.» Radiology 196(1): 239−244.
- Gupta, H., Wilkinson, R. A., Bogdanov, A. A., Jr., Callahan, R. J. and Weissleder, R. (1995). «Inflammation: Imaging with methoxy poly (ethylene glycol)-poly-l-lysine-dtpa, a long-circulating graft copolymer.» Radiology 197(3): 665−669.
- Gurfinkel, M., Ke, S., Wang, W., Li, C. and Sevick-Muraca, E. M. (2005). «Quantifying molecular specificity of alphavbeta3 integrin-targeted optical contrast agents with dynamic optical imaging.» J Biomed Opt 10(4):41 205 10(3): 34 019.
- Hama, Y., Urano, Y., Koyama, Y., Choyke, P. L. and Kobayashi, H. (2007). «Activatable fluorescent molecular imaging of peritoneal metastases following pretargeting with a biotinylated monoclonal antibody.» Cancer Res 67(8): 3809−3817.
- Hanaoka, K., Lubag, A. J., Castillo-Muzquiz, A., Kodadek, T. and Sherry, A. D. (2008). «The detection limit of a gd3H—based tl agent is substantially reduced when targeted to a protein microdomain.» Magn Reson Imaging 26(5): 608 617.
- Hardman, R. (2006). «A toxicologic review of quantum dots: Toxicity depends on physicochemical and environmental factors.» Environ Health Perspect 114(2): 116−172.
- Hashimoto, T., Meng, H. and Young, W. L. (2006). «Intracranial aneurysms: Links among inflammation, hemodynamics and vascular remodeling.» Neurological Research 28: 372−380.
- Heiskala, J., Nissila, I., Neuvonen, T., Jarvenpaa, S. and Somersalo, E. (2005). «Modeling anisotropic light propagation in a realistic model of the human head.» Appl Opt 44 (11): 2049−2057.
- Henkelman, R. M., Stanisz, G. J. and Graham, S. J. (2001). «Magnetization transfer in mri: A review.» NMR Biomed 14(2): 57−64.
- Heyn, C., Bowen, C. V., Rutt, B. K. and Foster, P. J. (2005). «Detection threshold of single spio-labeled cells with fiesta.» Magn Reson Med 53(2): 312−320.
- Hilderbrand, S. A., Kelly, K. A., Weissleder, R. and Tung, C. H. (2005). «Monofunctional near-infrared fluorochromes for imaging applications.» Bioconj Chem 16(5): 1275−1281.
- Hoffman, R. M. (2004). «Imaging tumor angiogenesis with fluorescent proteins.» Apmis 112(7−8):441−9 112(7−8): 441 449.
- Hoffman, R. M. (2005). «In vivo cell biology of cancer cells visualized with fluorescent proteins.» Curr Top Dev Biol 70: 121−144.
- Hooper, C. E., Ansorge, R. E., Browne, H. M. and Tomkins, P. (1990). «Ccd imaging of luciferase gene expression insingle mammalian cells.» JBioluminescence
- Chemiluminescence 5(2): 123−130.
- Hsieh, C. L., Xie, Z., Liu, Z. Y., Green, J. E., Martin, W.
- D., Datta, M. W., Yeung, F., Pan, D. and Chung, L. W. (2005). «A luciferase transgenic mouse model: Visualization of prostate development and its androgen responsiveness in live animals.» J Mol Endocrinol 35(2): 293−304.
- Inglese, M. and Ge, Y. (2004). «Quantitative mri: Hidden age-related changes in brain tissue.» Top Magn Reson Imaging 15(6): 355−363.
- Iqbal, S. and Lenz, H. J. (2004). «Angiogenesis inhibitors in the treatment of colorectal cancer.» Semin Oncol 31(6 Suppl 17): 10−16.
- Jacobs, R. E., Ahrens, E. T., Meade, T. J. and Fraser, S.
- E. (1999). «Looking deeper into vertebrate development.» Trends Cell Biol 9(2): 73−76.
- Jain, R. (1990) . «Vascular and interstitial barriers to delivery of therapeutic agents in tumors.» Cancer Metastasis Rev 9: 253−266.
- Jain, R. (1996). «Delivery of molecular medicine to solid tumors.» Science 271: 1079−1080.
- Jain, R., Schlenger, K., Hockel, M. and Yuan, F. (1997). «Quantitative angiogenesis assays: Progress and problems.» Nature Medicine 3(11): 1203−1208.
- Jain, R. K. (2001). «Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy. 28 refs.» Nature Medicine. 7(9): 987−989.
- Johnson, G. A., Benveniste, H., Black, R. D., Hedlund, L. W., Maronpot, R. R. and Smith, B. R. (1993). «Histology by magnetic resonance microscopy.» Magn Reson Q 9(1): 1−30.
- Kawai, Y., Sato, M. and Umezawa, Y. (2004). «Single color fluorescent indicators of protein phosphorylation for multicolor imaging of intracellular signal flow dynamics.» Anal Chem 76 (20): 6144−6149.
- Kay, J. (1994). «Statistical models for pet and spect data.» Stat Methods Med Res 3(1): 5−21.
- Kim, S. B., Ozawa, T., Watanabe, S. and Umezawa, Y. (2004). «High-throughput sensing and noninvasive imaging of protein nuclear transport by using reconstitution of split renilla luciferase.» Proc Natl Acad Sci USA 101 (32): 11 542−11 547.
- Kim, Y., Savellano, M., Weissleder, R. and Bogdanov, A. J. (2002). «Steady-state and dynamic contrast mr imaging of human prostate cancer xenograft tumors: A comparative study.» Techn Cancer Res Treat 1(1−7).
- Kim, Y. R., Savellano, M. D., Savellano, D. H., Weissleder, R. and Bogdanov, A., Jr. (2004). «Measurement of tumor interstitial volume fraction: Method and implication for drug delivery.» Magn Reson Med 52(3): 485−494.
- Kim, Y. R., Savellano, M. D., Weissleder, R. and Bogdanov, A., Jr. (2002). «Steady-state and dynamic contrast mr imaging of human prostate cancer xenograft tumors: A comparative study.» Technol Cancer Res Treat 1(6): 489−495.
- Kircher, M. F., Mahmood, U., King, R. S., Weissleder, R. and Josephson, L. (2003). «A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation.» Cancer Res 63(23): 81 228 125.
- Kirsch, J. E. (1991). «Basic principles of magnetic resonance contrast agents.» Top Magn Reson Imaging 3(2): 118.
- Klebanoff, S. J. (2005). «Myeloperoxidase: Friend and foe.» J Leukoc Biol 77(5): 598−625.
- Klibanov, A. L. (2006). «Microbubble contrast agents: Targeted ultrasound imaging and ultrasound-assisted drug-delivery applications.» Invest Radiol 41(3): 354−362.
- Klibanov, A. L. (2007). «Ultrasound molecular imaging with targeted microbubble contrast agents.» J Nucl Cardiol 14(6): 876−884.
- Klohs, W. D. and Hamby, J. M. (1999). «Antiangiogenic agents. 32 refs.» Curr Opin Biotechnol 8(4):449−54 10(6): 544−549.
- Kohn, S., Nagy, J. A., Dvorak, H. F. and Dvorak, A. M. (1992). «Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels.» Lab Invest 67(5): 596−607.
- Kornguth, S., Anderson, M., Turski, P., Sorenson, J., Robins, H. I., Cohen, J., Rappe, A. and Markley, J. (1990).
- Glioblastoma multiforme: Mr imaging at 1.5 and 9.4 t after injection of polylysine-dtpa-gd in rats.» Ajnr: American J Neuroradiology 11(2): 313−318.
- Kurhanewicz, J., Bok, R., Nelson, S. J. and Vigneron, D. B. (2008). «Current and potential applications of clinical 13c mr spectroscopy.» J Nucl Med 49(3): 341−344.
- Landis, C. S., Li, X., Telang, F. W., Molina, P. E., Palyka, I., Vetek, G. and Springer, C. S., Jr. (1999). «Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo.» Magn Reson Med 42(3): 467−478.
- Larson, D. R., Zipfel, W. R., Williams, R. M., Clark, S. W., Bruchez, M. P., Wise, F. W. and Webb, W. W. (2003). «Water-soluble quantum dots for multiphoton fluorescence imaging in vivo.» Science 300(5624): 1434−1436.
- Larson-, S. M. and Schoder, H. (2009). «New pet tracers for evaluation of solid tumor response to therapy.» Q J Nucl Med Mol Imaging 53(2): 158−166.
- Lauffer, R. B. (1987). «Paramagnetic metal complexes as water proton relaxation agents for nmr imaging: Theory and design.» Chem. Rev. 87: 901−927.
- Lauffer, R. B. (1990). «Mechanisms of magnetic resonance contrast enhancement by relaxivity and magnetic susceptibility agents.» Invest Radiol 25 Suppl 1: S32−33.
- Lauffer, R. B., McMurry, T. J., Dunham, S. O., Scott, D. M., Parmelee, D. J. and Dumas, S. (1997). Bioactivated diagnostic imaging contrast agents. Application: WO
- WO, (Epix Medical, Inc., USA). 80 pp.
- Laxman, B., Hall, D. E., Bhojani, M. S., Hamstra, D. A., Chenevert, T. L., Ross, B. D. and Rehemtulla, A. (2002). «Noninvasive real-time imaging of apoptosis.» Proc Natl Acad Sci USA 99(26): 16 551−16 555.
- Lewin, M., Bredow, S., Sergeyev, N., Marecos, E., Bogdanov, A., Jr. and Weissleder, R. (1999). «In vivo assessment of vascular endothelial growth factor-induced angiogenesis.» Int J Cancer 83(6): 798−802.
- Lewin, M., Bredow, S., Sergeyev, N., Marecos, E., Bogdanov, A. J. and Weissleder, R. (1999). What is the effect of tumoral vegf overproduction on mr imaging? Proc 7th Sci Mtg Int Soc Magn Reson Med, Philadelphia, PA, ISMRM.
- Lewin, M., Clement, 0., Belguise-Valladier, P., Tran, L., Cuenod, C. A., Siauve, N. and Frija, G. (2001). «Hepatocyte targeting with gd-eob-dtpa: Potential application for gene therapy.» Invest Radiol 36(1): 9−14.
- Li, Z., Wang, K., Tan, W., Li, J., Fu, Z., Ma, C., Li, H., He, X. and Liu, J. (2006). «Immunofluorescent labeling of cancer cells with quantum dots synthesized in aqueous solution.» Anal Biochem 354(2): 169−174.
- Lichtenbeld, H. C., Ferarra, N., Jain, R. K. and Munn, L. L. (1999). «Effect of local anti-vegf antibody treatment on tumor microvessel permeability.» Microvasc Res 57(3): 357 362.
- Lin, Y., Weissleder, R. and Tung, C. H. (2002). «Novel near-infrared cyanine fluorochromes: Synthesis, properties, and bioconjugation.» Bioconj Chem 13(3): 605−610.
- Locke, L. W., Chordia, M. D., Zhang, Y., Kundu, B., Kennedy, D., Landseadel, J., Xiao, L., Fairchild, K. D., Berr, S. S., Linden, J. and Pan, D. (2009). «A novel neutrophil-specific pet imaging agent: CfIfIfk-peg-64cu.» J Nucl Med 50 (5): 790−797.
- Louie, A. Y., Huber, M. M., Ahrens, E. T., Rothbacher, U., Moats, R., Jacobs, R. E., Fraser, S. E. and Meade, T. J. (2000). «In vivo visualization of gene expression using magnetic resonance imaging.» Nat biotechnol 23(7):879−84 18(3): 321−325.
- Lucignani, G. (2008). «Pet-mri synergy in molecular, functional and anatomical cancer imaging.» Eur J Nucl Med Mol Imaging 35(8): 1550−1553.
- Lukyanov, K. A., Chudakov, D. M., Fradkov, A. F., Labas, Y. A., Matz, M. V. and Lukyanov, S. (2006). «Discovery and properties of gfp-like proteins from nonbioluminescent anthozoa.» Methods Biochem Anal 47: 121−138.
- Mahmood, U., Tung, C. H., Bogdanov, A., Jr. and Weissleder, R. (1999). «Near-infrared optical imaging of protease activity for tumor detection.» Radiology 213(3): 866−870.
- Manabe, Y., Longley, C. and Furmanski, P. (1986). «Highlevel conjugation of chelating agents onto immunoglobulins: Use of an intermediary poly (1-lysine)-diethylenetriaminepentaacetic acid carrier.» Biochimica et Biophysica Acta 883(3): 460−467.
- Marchal, G., Bosnians, H., Van Hecke, P., Speck, U., Aerts, P., Vanhoenacker, P. and Baert, A. L. (1990). «Mr angiography with gadopentetate dimeglumine-polylysine: Evaluation in rabbits.» Amer J Roentgenol 155(2): 407−411.
- Marecos, E., Weissleder, R. and Bogdanov, A., Jr. (1998). «Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model.» Bioconj Chem 9(2): 184 191.
- Martin, W. R. (2007). «Mr spectroscopy in neurodegenerative disease.» Mol Imaging Biol 9(4): 196−203.
- Massoud, T. and Gambhir, S. (2003). «Molecular imaging in living subjects: Seeing fundamental biological processes in a new light.» Genes and Development 17: 545−580.
- Massoud, T. F. and Gambhir, S. S. (2007). «Integrating noninvasive molecular imaging into molecular medicine: An evolving paradigm.» Trends Mol Med 13(5): 183−191.
- Matsouka, H., Hamada, M., Honda, T., Kawakami, H., Abe, M., Shigematsu, Y., Sumimoto, T. and Hiwada, K. (1994). «Evaluation of acute myocarditis and pericarditis by gd-dtpa enhanced magnetic resonance imaging.» Eur Heart J 15(2): 283−284.
- Matz, M. V., Fradkov, A. F., Labas, Y. A., Savitsky, A. P., Zaraisky, A. G., Markelov, M. L. and Lukyanov, S. A. (1999). «Fluorescent proteins from nonbioluminescent anthozoa species.» Nat Biotechnol 17(10): 969−973.
- Matz, M. V., Lukyanov, K. A. and Lukyanov, S. A. (2002). «Family of the green fluorescent protein: Journey to the end of the rainbow.» Bioessays 24(10): 953−959.
- Mayer, B., Spatz, H., Funke, I., Johnson, J. P. and Schildberg, F. W. (1998). «De novo expression of the cell adhesion molecule e-selectin on gastric cancer endothelium.» Langenbecks Arch Surg 383(1): 81−86.
- McDonald, D. M. and Choyke, P. L. (2003). «Imaging of angiogenesis: From microscope to clinic.» Nature Med 9(6): 713−725.
- Medarova, Z., Castillo, G., Dai, G., Bolotin, E., Bogdanov, A. and Moore, A. (2007). «Noninvasive magnetic resonance imaging of microvascular changes in type 1 diabetes.» Diabetes56 (11)': 2677−2682.
- Merbach, A. E. and Toth, E. (2001). The chemistry of contrast agents in medical magnetic resonance imaging. Chichester, John Wiley & Sons, Ltd.
- Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S. and Weiss, S. (2005). «Quantum dots for live cells, in vivo imaging, and diagnostics.» Science 307(5709): 538 544.
- Miyawaki, A. and Tsien, R. Y. (2000). «Monitoring protein conformations and interactions by fluorescence resonance energy transfer between mutants of green fluorescent protein.» Methods Enzymol 327: 472−500.
- Moats, R. A., Fraser, S. E. and Meade, T. J. (1997). «A «Smart» Magnetic resonance imaging agent that reports on specific enzymatic activity.» Angewandte Chemie Int.Ed. 36: 726−731.
- Mohler, J. and Sharief, Y. (1993). «Flow cytometric assay of pinocytosis: Correlation with membrane ruffling and metastatic potential in the dunning r-3327 rat prostatic adenocarcinoma model.» Cytometry 14 (7): 826−831.
- Momota, H. and Holland, E. C. (2005). «Bioluminescence technology for imaging cell proliferation.» Curr Opin Biotechnol 16(6): 681−686.
- Monici, M. (2005). «Cell and tissue autofluorescence research and diagnostic applications.» Biotechnol Annu Revll: 227−256.
- Moore, A., Marecos, E., Bogdanov, A., Jr. and Weissleder, R. (2000). «Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model.» Radiology 214 (2): 568−574.
- Moore, A., Marecos, E., Simonova, M., Weissleder, R. and Bogdanov, A. J. (1998). «Novel gliosarcoma cell line expressing green fluorescent protein: A model for quantitative assessment of angiogenesis.» Microvascular Res 56: 145−153.
- Moseley, M., White, D., Wang, S., Wikstrom, M. G., Dupon, J., Gobbel, G., Roth, K. and Brasch, R. (1989). «Vascular mapping using albumin-(gd-dtpa), an intravascular mr contrast agent, and projection mr imaging.» J Comput Assist Tomoqr 30(3): 525−34.
- Murray, C., Norris, D. and Bawendi, M. (1993). «Synthesis and characterization of nearly monodisperse cde (e = s, se, te) semiconductor nanocrystallites.» J. Am. Chem. Soc. 115: 8706−8715.
- Niu, G. and Chen, X. (2008). «Has molecular and cellular imaging enhanced drug discovery and drug development?» Drugs R D 9(6): 351−368.
- Ntziachristos, V. (2006). «Fluorescence molecular imaging.» Annu Rev Biomed Enq 8: 1−33.
- Ntziachristos, V., Bremer, C. and Weissleder, R. (2003). «Fluorescence imaging with near-infrared light: New technological advances that enable in vivo molecular imaging.» Eur Radiol. 13(1): 195−208.
- Ntziachristos, V., Tung, C.-H., Bremer, C. and Weissleder, R. (2002). «Fluorescence molecular tomography resolves protease activity in vivo.» Nature Medicine 8(7): 757−760.
- Ntziachristos, V., Tung, C. H., Bremer, C. and Weissleder, R. (2002). «Fluorescence molecular tomography resolves protease activity in vivo.» Nat Med 8(7): 757−760.
- Ntziachristos, V., Yodh, A. G., Schnall, M. and Chance, B. (2000). «Concurrent mri and diffuse optical tomography of breast after indocyanine green enhancement.» Proc Natl Acad Sci USA 97(6): 2767−2772.
- Olivo, M. and Wilson, B. C. (2004). «Mapping ala-induced ppix fluorescence in normal brain and brain tumour using confocal fluorescence microscopy.» Int J Oncol' 25(1): 3745.
- Ono, M., Torisu, H., Fukushi, J., Nishie, A. and Kuwano, M. (1999). «Biological implications of macrophage infiltration in human tumor angiogenesis. 19 refs. .» Cancer Chemother Pharmacol 43 Suppl: S69−71.
- Otto-Duessel, M., Khankaldyyan, V., Laug, W. E., Rosol, M., Gonzalez-Gomez, I. and Jensen, M. C. (2006). «In vivo testing of renilla luciferase substrate analogs in an orthotopic murine model of human glioblastoma.» Mol Imag 5 (2): 57−64.
- Ozawa, T., Kaihara, A., Sato, M., Tachihara, K. and Umezawa, Y. (2001). «Split luciferase as an optical probe for detecting protein-protein interactions in mammalian cells based on protein splicing.» Anal Chem 73(11): 25 162 521.
- Palmer, G. M., Keely, P. J., Breslin, T. M. and Ramanujam, N. (2003). «Autofluorescence spectroscopy of normal and malignant human breast cell lines.» Photochem Photobiol 78(5): 462−469.
- Paulmurugan, R. and Gambhir, S. S. (2005). «Novel fusion protein approach for efficient high-throughput screening ofsmall molecule-mediating protein-protein interactions in cells and living animals.» Cancer Res 65(16): 7413−7420.
- Paulmurugan, R., Massoud, T. F., Huang, J. and Gambhir, S. S. (2004). «Molecular imaging of drug-modulated proteinprotein interactions in living subjects.» Cancer Res 64(6): 2113−2119.
- Perman, W. H., Gado, M. H., Larson, K. B. and Perlmutter, J. S. (1992). «Simultaneous mr acquisition of arterial and brain signal-time curves.» Magn Reson Med 28(1): 74−83.
- Peters, A. M. (1998). «The use of nuclear medicine in infections. 63 refs.» Br J Radiol 71(843): 252−261.
- Peters, A. M., Osman, S., Reavy, H. J., Chambers, B., Deenmamode, M. and Lewis, S. M. (1986). «Erythrocyte radiolabelling: In vitro comparison of chromium, technetium, and indium in undamaged and heat damaged cells.» J Clin Pathol 39(7): 717−721.
- Petrovsky, A., Schellenberger, E., Josephson, L., Weissleder, R. and Bogdanov, A., Jr. (2003). «Near-infrared fluorescent imaging of tumor apoptosis.» Cancer Res. 63(8): 1936−1942.
- Phelps, M. E. (2000). «Inaugural article: Positron emission tomography provides molecular imaging of biological processes.» Proc Natl Acad Sci USA 97(16): 9226−9233.
- Pichler, B. J., Wehrl, H. F. and Judenhofer, M. S. (2008). «Latest advances in molecular imaging instrumentation.» J Nucl Med 49 Suppl 2: 5S-23S. ~~
- Piston, D. W., Masters, B. R. and Webb, W. W. (1995). «Three-dimensionally resolved nad (p)h cellular metabolic redox imaging of the in situ cornea with two-photon excitation laser scanning microscopy.» J Microscopy 178(Pt 1): 20−27.
- Pitterle, D. M., Sperling, R. T., Myers, M. G., Jr., White, M. F. and Blackshear, P. J. (1999). «Early biochemical events in insulin-stimulated fluid phase endocytosis.» Amer J Physiol 276(1 Pt 1): E94-E105.
- Port, M., Idee, J. M., Medina, C., Robic, C., Sabatou, M. and Corot, C. (2008). «Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: A critical review.» Biometals 21(4): 469−490.
- Querol, M. and Bogdanov, A., Jr. (2006). «Amplification strategies in mr imaging: Activation and accumulation of sensing contrast agents (seas).» J Magn Reson Imag 24(5): 971−982.
- Querol, M. and Bogdanov, A., Jr. (2008). «Environmentsensitive and enzyme-sensitive mr contrast agents.» Handb Exp Pharmacol (185 Pt 2): 37−57.
- Querol, M., Chen, J. and Bogdanov, A., Jr (2006). «A paramagnetic contrast agent with myeloperoxidase-sensing properties.» Org. Biomol. Chem. 4: 1887 1895.
- Querol, M., Chen, J. W., Weissleder, R. and Bogdanov, A., Jr. (2005). «Dtpa-bisamide-based mr sensor agents for peroxidase imaging.» Org Lett 7(9): 1719−1722.
- Racoosin, E. L. and Swanson, J. A. (1989). «Macrophage colony-stimulating factor (rm-csf) stimulates pinocytosis in bone marrow-derived macrophages.» J Exp Med 170(5): 1635−1648.
- Racoosin, E. L. and Swanson, J. A. (1993). «Macropinosome maturation and fusion with tubular lysosomes in macrophages.» J Cell Biol 121(5): 1011−1020.
- Rahmim, A. and Zaidi, H. (2008). «Pet versus spect: Strengths, limitations and challenges.» Nucl Med Commun 29(3): 193−207.
- Reichardt, W., Hu-Lowe, D., Torres, D., Weissleder, R. and Bogdanov, A., Jr. (2005). «Imaging of vegf receptor kinase inhibitor-induced antiangiogenic effects in drug-resistant human adenocarcinoma model.» Neoplasia (New York) 7(9): 847−853.
- Ripoll, J., Yessayan, D., Zacharakis, G. and Ntziachristos, V. (2005). «Experimental determination of photon propagation in highly absorbing and scattering media.» J Opt Soc Am A Opt Image Sci Vis 22(3): 546−551.
- Rowland, D. J. and Cherry, S. R. (2008). «Small-animal preclinical nuclear medicine instrumentation and methodology.» Semin Nucl Med 38(3): 209−222.
- Roy, R. and Sevick-Muraca, E. (1999). «Truncated newton’s optimization scheme for absorption and fluorescence optical tomography: Part i theory and formulation.» Opt Express 4(10): 353−371.
- Rudin, M. and Weissleder, R. (2003). «Molecular imaging in drug discovery and development.» Nat Rev Drug Discov 2(2): 123−131.
- Runnels, J. M., Zamiri, P., Spencer, J. A., Veilleux, I., Wei, X., Bogdanov, A. and Lin, C. P. (2006). «Imaging molecular expression on vascular endothelial cells by in vivo immunofluorescence microscopy.» Mol Imag 5(1): 31−40.
- Sarikaya, I., Sarikaya, A. and Holder, L. E. (2001). «The role of single photon emission computed tomography in bone imaging.» Semin Nucl Med 31(1): 3−16.
- Sato, M., Ozawa, T., Inukai, K., Asano, T. and Umezawa, Y. (2002). «Fluorescent indicators for imaging protein phosphorylation in single living cells.» Nature Biotechnol 20: 287−294.
- Schellenberger, E. A., Bogdanov, A., Jr., Petrovsky, A., Ntziachristos, V., Weissleder, R. and Josephson, L. (2003). «Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy.» Neoplasia 5(3): 187−192.
- Schellenberger, E. A., Sosnovik, D., Weissleder, R. and Josephson, L. (2004). «Magneto/optical annexin v, a multimodal protein.» Bioconjug Chem 15(5): 1062−1067.
- Serganova, I., Mayer-Kukuck, P., Huang, R. and Blasberg, R. (2008). «Molecular imaging: Reporter gene imaging.» Handb Exp Pharmacol (185 Pt 2): 167−223.
- Sevick-Muraca, E. M., Houston, J. P. and Gurfinkel, M. (2002). «Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents.» Curr Opin Chem Biol 6(5): 642−650.
- Shabani, F., McNeil, J. and Tippett, L. (1998). «The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (timp-1) by hypochlorous acid (hoci) is suppressed by anti-rheumatic drugs.» Free Radic Res 28(2): 115−123.
- Shapiro, S. D. (1999). «Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth. 25 refs.» Thrombosis & Haemostasis 82(2): 846−849.
- Shen, T., Weissleder, R., Papisov, M., Bogdanov, A. and Brady, T. (1993). «Monocrystalline iron oxide nanocompounds (mion): Physiochemical properties.» Magn Reson Med 29: 599 604.
- Sherry, A. D. and Woods, M. (2008). «Chemical exchange saturation transfer contrast agents for magnetic resonance imaging.» Annu Rev Biomed Eng 10: 391−411.
- Shoenut, J. P., Semelka, R. C., Silverman, R., Yaffe, C. S. and Micflikier, A. B. (1993). «Magnetic resonance imaging in inflammatory bowel disease.» J Clin Gastroenterol 17(1): 73−78.
- Signore, A., Annovazzi, A., Corsetti, F., Capriotti, G., Chianelli, M., De Winter, F. and Scopinaro, F. (2002). «Biological imaging for the diagnosis of inflammatory conditions.» BioDrugs 16(4): 241−259.
- Sikora, M., Interewicz, B. and Olszewski, W. L. (2005). «Contemporary methods for detection of microbial infections in transplanted tissues.» Ann Transplant 10(4): 11−16.
- Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D. and Li, K. C. (1998). «Detection of tumor angiogenesis in vivo by alphavbeta3-targeted magnetic resonance imaging.» Nature Med 4(5): 623−626.
- Sipkins, D. A., Wei, X., Wu, J. W., Runnels, J. M., Cote, D., Means, T. K., Luster, A. D., Scadden, D. T. and Lin, C. P. (2005). «In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment.» Nature 435(7044): 969−973.
- Skouri, H. N., Dec, G. W., Friedrich, M. G. and Cooper, L. T. (2006). «Noninvasive imaging in myocarditis.» J Am Coll Cardiol 48 (10): 2085−2093.
- So, M. K., Xu, C., Loening, A. M., Gambhir, S. S. and Rao, J. (2006). «Self-illuminating quantum dot conjugates for in vivo imaging.» Nat Biotechnol 24(3): 339−343.
- Sosnovik, D. E., Nahrendorf, M. and Weissleder, R. (2008). «Targeted imaging of myocardial damage.» Nat Clin Pract Cardiovasc Med 5 Suppl 2: S63−70.
- Stetler-Stevenson, W. G., Aznavoorian, S. and Liotta, L. A. (1993). «Tumor cell interactions with the extracellular matrix during invasion and metastasis. 189 refs.» Ann Rev Cell Biol 9: 541−573.
- Stevens, D. L., Bryant, A. E., Huffman, J., Thompson, K. and Allen, R. C. (1994). «Analysis of circulating phagocyte activity measured by whole blood luminescence: Correlations with clinical status.» J Infect Pis 170(6): 1463−1472.
- Tanaka, F., Miyahara, R., Ohtake, Y., Yanagihara, K., Fukuse, T., Hitomi, S. and Wada, H. (1998). «Lewis y antigen expression and postoperative survival in non-small cell lung cancer.» Ann Thorac Surg 66(5): 1745−1750.
- Tofts, P. S. and Kermode, A. G. (1991). «Measurement of the blood-brain barrier permeability and leakage space using dynamic mr imaging. 1. Fundamental concepts.» Magn Reson Med 17: 357−367.
- Torchilin, V., Ed. (1995). Handbook of targeted delivery of imaging agents. Boca Raton FL, CRC Press.
- Toth, E., Helm, L. and Merbach, A. E. (2002). «Relaxivity of mri contrast agents.» Top Curr Chem 221(Contrast Agents I): 61−101.
- Trehin, R., Figueiredo, J. L., Pittet, M. J., Weissleder, R., Josephson, L. and Mahmood, U. (2006). «Fluorescent nanoparticle uptake for brain tumor visualization.» Neoplasia (New York) 8(4): 302−311.
- Trokowski, R., Ren, J., Kalman, F. K. and Sherry, A. D. (2005). «Selective sensing of zinc ions with a paracest contrast agent.» Angew Chem Int Ed Engl 44(42): 6920−6923.
- Tsien, R. Y. (1998). «The green fluorescent protein.» Annu Rev Biochem 67: 509−544.
- Tsui, B. M. (1996). «The aapm/rsna physics tutorial for residents. Physics of spect.» Radiographics 16(1): 173−183.
- Tung, C. H., Bredow, S., Mahmood, U. and Weissleder, R. (1999). «Preparation of a cathepsin d sensitive near-infrared fluorescence probe for imaging.» Bioconj Chem 10(5): 892−896.
- Valadon, P., Garnett, J. D., Testa, J. E., Bauerle, M., Oh, P. and Schnitzer, J. E. (2006). «Screening phage displaylibraries for organ-specific vascular immunotargeting in vivo.» Proc Natl Acad Sci USA103(2): 407−412.
- Veithen, A., Cupers, P., Baudhuin, P. and Courtoy, P. J. (1996). «V-src induces constitutive macropinocytosis in rat fibroblasts.» J Cell Sci 109: 2005−2012.
- Veronese, M. L. and O’Dwyer, P. J. (2004). «Monoclonal antibodies in the treatment of colorectal cancer.» Eur J Cancer 40(9): 1292−1301.
- Vexler, V., Berthezene, Y., Clement, O., Muhler, A., Rosenau, W., Moseley, M. and Brasch, R. (1992). «Detection of zonal renal ischemia with contrast-enhanced mr imaging with a macromolecular blood pool contrast agent.» J Magn Reson Imag 2: 311−319.
- Vexler, V. S., Clement, O., Schmitt-Willich, H. and Brasch, R. C. (1994). «Effect of varying the molecular weight of the mr contrast agent gd-dtpa-polylysine on blood pharmacokinetics and enhancement patterns.» J Magn Reson Imag 4 (3): 381−388 .
- Wadas, T. J., Wong, E. H., Weisman, G. R. and Anderson, C. J. (2007). «Copper chelation chemistry and its role in copper radiopharmaceuticals.» Curr Pharm Pes 13(1): 3−16.
- Wang, W., Ke, S., Wu, Q., Charnsangavej, C., Gurfinkel, M., Gelovani, J. G., Abbruzzese, J. L., Sevick-Muraca, E. M. and Li, C. (2004). «Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts.» Mol Imag 3(4): 343−351.
- Ward, K. M. and Balaban, R. S. (2000). «Determination of ph using water protons and chemical exchange dependent saturation transfer (cest).» Magn Reson Med 44(5): 799−802.
- Weisskoff, R. M., Zuo, C. S., Boxerman, J. L. and Rosen, B. R. (1994). «Microscopic susceptibility variation and transverse relaxation: Theory and experiment.» Magn Reson Med 31 (6): 601−610.
- Weissleder, R. (2002). «Scaling down imaging: Molecular mapping of cancer in mice.» Nature Revs Cancer 2(1): 1−8.
- Weissleder, R. (2006). «Molecular imaging in cancer.» Science 312(5777): 1168−1171.
- Weissleder, R., Bogdanov, A., Jr., Tung, C. H. and Weinmann, H. J. (2001). «Size optimization of synthetic graft copolymers for in vivo angiogenesis imaging.» Bioconj Chem 12 (2): 213−219.
- Weissleder, R., Bogdanov, A. and Papisov, M. (1992). «Drug targeting in magnetic resonance imaging.» Mag Res Quart 8(1): 55−63.
- Weissleder, R., Cheng, H. C., Marecos, E., Kwong, K. and Bogdanov, A., Jr. (1998). «Non-invasive in vivo mapping of tumour vascular and interstitial volume fractions.» Eur J Cancer 34(9): 1448−1454.
- Weissleder, R., Heautot, J. F., Schaffer, B. K., Nossiff, N., Papisov, M. I., Bogdanov, A., Jr. and Brady, T. J. (1994). «Mr lymphography: Study of a high-efficiency lymphotrophic agent.» Radiology 191(1): 225−230.
- Weissleder, R. and Mahmood, U. (2001). «Molecular imaging. «Radiology 219(2): 316−333.
- Weissleder, R., Tung, C. H., Mahmood, U. and Bogdanov, A., Jr. (1999). «In vivo imaging of tumors with proteaseactivated near-infrared fluorescent probes.» Nat Biotechnol 17 (4): 375−378.
- Weissleder, R., Wang, Y. M., Papisov, M., Bogdanov, A., Schaffer, B., Brady, T. J. and Wittenberg, J. (1993). «Polymeric contrast agents for mr imaging of adrenal glands.» J Magn Reson Imag 3(1): 93−97.
- Welsh, S. and Kay, S. A. (1997). «Reporter gene expression for monitoring gene transfer. 62 refs.» Curr Opin Biotechnol 8(5): 617−622.
- Wernick, M. N., Infusino, E. J. and Milosevic, M. (1999). «Fast spatio-temporal image reconstruction for dynamic pet.» IEEE Trans Med Imaging 18(3): 185−195.
- West, J. L. and Halas, N. J. (2003). «Engineered nanomaterials for biophotonics applications: Improving sensing, imaging, and therapeutics.» Nanomaterials 5:28 592.
- Wolff, S. D. and Balaban, R. S. (1989). ."Magnetization transfer contrast (mtc) and tissue water proton relaxation in vivo.» Magn Reson Med 10(1): 135−144.
- Wood, M. L. and Hardy, P. A. (1993). «Proton relaxation enhancement.» J Magn Reson Imag 3(1): 149−156.
- Wu, J., Perelman, L., Dasari, R. R. and Feld, M. S. (1997). «Fluorescence tomographic imaging in turbid media using early-arriving photons and laplace transforms.» Proc Natl Acad Sci U S A 94 (16): 8783−8788 .
- Wuest, F. (2007). «Fluorine-18 labeling of small molecules: The use of 18f-labeled aryl fluorides derived from no-carrier-added 18f. fluoride as labeling precursors.» Ernst Scherinq Res Found Workshop (62): 51−78.
- Yarnykh, V. L. and Yuan, C. (2002). «Tl-insensitive flow suppression using quadruple inversion-recovery.» Magn Reson Med 48 (5): 899−905.
- Yuan, F., Salehi, H. A., Boucher, Y., Vasthare, U. S., Turaa, R. F. and Jain, R. K. (1994). «Vascular permeability and microcirculation of glioma and mammary carcinomas transplanted in rat and mouse cranial windows.» Cancer Res 54: 4564−4568.
- Zacharakis, G., Kambara, H., Shih, H., Ripoll, J., Grimm, J., Saeki, Y., Weissleder, R. and Ntziachristos, V. (2005). «Volumetric tomography of fluorescent proteins through small animals in vivo.» Proc Natl Acad Sci USA 102(51): 18 252−18 257.
- Zador, Z., Stiver, S., Wang, V. and Manley, G. T. (2009). «Role of aquaporin-4 in cerebral edema and stroke.» Handb Exp Pharmacol (190): 159−170.
- Zaharchuk, G., Bogdanov, A. A., Jr., Marota, Shimizu-Sasamata, M., Weisskoff, R. M., Kwong, Jenkins, B. «Continuous volume and1. J. J., K. K. ,
- E. and Frangioni, for near-infrared 354−364.
- J. V. (2002). fluorescence
- Zenita, K., Kirihata, Y., Kitahara, A., Shigeta, K., Higuchi, K., Hirashima, K., Murachi, T., Miyake, M., Takeda, T. and Kannagi, R. (1988). «Fucosylated type-2 chain polylactosamine antigens in human lung cancer.» Int J Cancer 41(3): 344−349.
- Zhang, S., Merritt, M., Woessner, D. E., Lenkinski, R. E. and Sherry, A. D. (2003). «PARACEST agents: Modulating mricontrast via water proton exchange.» Acc Chem Res 36(10): 783−790.
- Zhang, S., Winter, P., Wu, K. and Sherry, A. D. (2001). «A novel europium (iii)-based mri contrast agent.» J Am Chem Soc 123 (7): 1517−1518.
- Zolotukhin, S., Potter, M., Hauswirth, W., Guy, J. and Muzyczka, N. (1996). «A «Humanized» Green fluorescent protein cdna adapted for high-level expression in mammalian cells.» J. Virology 70(7): 4646−4654.9 h